Zühlke Ventures has backed the medical device developer's series A round, which was led by Arboretum Ventures.
Koya Medical, a US-based developer of treatments for lymphedema and vein disease, received $11m yesterday in a series A round featuring Zühlke Ventures, a subsidiary of innovation service provider Zühlke.
Venture capital firm Arboretum Ventures led the round, which included Aphelion Capital, Scientific Health Development Partners, Bolt and InnerProduct Partners.
Founded in 2018, Koya has created a wearable compression system called Dayspring to treat cancer-related chronic lymphedema and venous insufficiency, and has secured US regulatory clearance for its product.
Koya’s…
